Bank of America’s Kiora Pharmaceuticals KPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding KPRX
ACM
VCM
XT
VFT
TSS
RC
Bank of America's KPRX Position: Q1 2026 in Review
Bank of America sold out of Kiora Pharmaceuticals (KPRX) in Q1 2026, closing a stake of 29 shares — an estimated $57 sold.
Bank of America first reported a position in KPRX in Q1 2020 and held it in 9 quarters. The position peaked at $4K in Q1 2020. 18 funds tracked by Wall St. Rank hold KPRX as of Q1 2026.
- Bank of America reported no remaining Kiora Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- Bank of America sold 29 Kiora Pharmaceuticals shares in Q1 2026, an estimated $57.
- Bank of America first reported a position in Kiora Pharmaceuticals in Q1 2020 and held it in 9 quarters.
- Bank of America's Kiora Pharmaceuticals position peaked at $4K in Q1 2020.
- 18 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.